Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia [6]

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{15ade83ce09e464fb24134d0634d85d8,

title = "Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia [6]",

author = "Oo, \{Thein H.\}",

year = "2005",

month = dec,

doi = "10.1097/01.smj.0000190101.56301.a2",

language = "English (US)",

volume = "98",

pages = "1227--1228",

journal = "Southern Medical Journal",

issn = "0038-4348",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia [6]

AU - Oo, Thein H.

PY - 2005/12

Y1 - 2005/12

UR - https://www.scopus.com/pages/publications/30344488413

UR - https://www.scopus.com/pages/publications/30344488413#tab=citedBy

U2 - 10.1097/01.smj.0000190101.56301.a2

DO - 10.1097/01.smj.0000190101.56301.a2

M3 - Letter

C2 - 16440930

AN - SCOPUS:30344488413

SN - 0038-4348

VL - 98

SP - 1227

EP - 1228

JO - Southern Medical Journal

JF - Southern Medical Journal

IS - 12

ER -